Radiation Dose Management Market Size, Leaders and Future Scope

Healthcare IT Radiation Dose Management Market to Cross $1.7 billion by 2023

Š P&S Intelligence. All rights reserved

1

The rising concern associated with radiation exposure, increasing awareness and industry initiatives regarding the issue, and surging prevalence of chronic diseases are some of the factors responsible for the growth of the radiation dose management market. In 2016, the market generated a revenue of $129.8 million, and it is expected to attain a size of more than $1700.0 million by 2023, advancing at a CAGR of 46.0% during the forecast period (2017– 2023).

Radiation dose management refers to a solution that can be integrated with medical systems, such as electronic health record (EHR), picture archiving and communication system (PACS), and radiology information system (RIS), to monitor, archive, and track the radiation exposure and aid in improving patient safety. Based on product, the radiation dose management market is bifurcated into solutions and services. Of these, during the historical period (2013–2016), solutions dominated the market, and these are projected to continue dominating it during the forecast period.

Download report sample at: https://www.psmarketresearch.com/market-analysis/radiationdose-management-market/report-sample These solutions help in evaluating and tracking the radiation emitted by various modalities, such as fluoroscopy & interventional imaging, computed tomography (CT), and nuclear medicine devices.

Further, on the basis of solution, the RDM market is categorized into standalone and integrated solutions. Of the two, during 2013– 2016, integrated solutions led the market in terms of revenue, and these are expected to maintain their lead during the forecast period. This is attributed to their high efficiency and easy integration with EHR, PACS, and RIS to evaluate the dose and track patient safety.

© P&S Intelligence. All rights reserved

2

One of the main purposes of radiological protection is to prevent the patient from the adverse effects of radiation. Exposure to high radiation doses over a short period can sometimes cause lifethreating diseases, such as cancer and radiation sickness, symptomized by fainting, nausea, vomiting, hair loss, diarrhea, bleeding, confusion, and mouth and skin sores. Radiation exposure not only affects patients, but it can also affect the public, as well as those inside medical and emergency settings. Therefore, the need to check radiation exposure is boosting the growth of the radiation dose management market.

For instance, as per the United States Food and Drug Administration (USFDA), for nuclear medicine, the average adult effective dose is between 0.2 and 416 mSv and estimated dose equivalent (no. of chest X-rays) is 10–2050. Further, the incidence of chronic diseases, such as chronic obstructive pulmonary disease, cancer, hepatitis, acquired immunodeficiency syndrome, and cardiovascular diseases, is growing. These diseases are diagnosed by different imaging techniques, such as CT scan, which need various radioactive compounds to detect the disease.

Further, to ensure the safety of patients and optimize device performance, the Medical Imaging and Technology Alliance is working with imaging equipment manufactures to help them maintain international standards for their equipment and offering expert recommendation on safety and quality checks. In 2010, the USFDA introduced an initiative to decrease unnecessary radiation from medical imaging equipment and spread awareness on the use of imaging procedures only when required. Owing to such initiatives, patients nowadays are becoming aware about the

Š P&S Intelligence. All rights reserved

3

absorption of radiation, which, in turn, is resulting in the growth of the radiation dose management market.

Hence, the growing awareness on the adverse effects of radiation exposure, governments’ surging initiatives, and increasing incidence of chronic diseases are predicted to augment the market growth.

Read More: https://www.psmarketresearch.com/marketanalysis/radiation-dose-management-market

Š P&S Intelligence. All rights reserved

4

Disclaimer: P&S Intelligence always keeps its customers’ interests at the core while carrying out research activities. P&S Intelligence ensures the reliability and accuracy of information and data provided in its market research publications. However, the information in publications is subject to fluctuations, as it is based on primary interviews of officials from various companies or organizations. P&S Intelligence is not responsible for any incorrect data provided by the key industry players of the concerned domain. The information or analysis in P&S Intelligence publications represents opinions based on research and should not be interpreted as statements of fact. Information in this report was believed to be correct at the time of publication, but cannot be guaranteed. P&S Intelligence does not endorse any product, service, or vendor depicted in its research publications.

All intellectual properties, including trademarks and copyrights, belong to their respective owners and may be protected by copyright. Under no circumstance can these be reproduced in any form without prior written agreement of their owners.

An order for market research report is intended for internal use of the company only and not for disclosure to third parties or any other publication in general. No service, report, or part thereof provided by P&S Intelligence can be reproduced, republished, resold, revealed, distributed, circulated, or sublicensed in any medium or form now realized or hereafter become realized, including but not limited to, all forms of optical-based media, magnetic, electronic, or digital, without a written permission from Prescient & Strategic Intelligence Pvt. Ltd.

Kindly write to: enquiry@psmarketresearch.com B-13, Sector – 2, Noida, U.P. – 201301, INDIA Contact No: +91 120 4541 337 US/Canada Toll-Free: 1-888-778-7886 © P&S Intelligence. All rights reserved

5